Half of American workers support COVID-19 vaccination, mask mandates in workplace
Aug 27, 2021
The poll was conducted before the FDA granted full approval to the Pfizer COVID-19 vaccine.
FDA approves first interchangeable biosimilar for inflammatory diseases
Oct 19, 2021
Cyltezo is first interchangeable monoclonal antibody for rheumatoid, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis and chronic plaque psoriasis.
Medicare could negotiate drug prices under Democrat proposal
Nov 03, 2021
For the first time, the measure would enable the federal government to negotiate prices for medications covered by Medicare.
COVID-19 vaccine patent rules reconsidered by World Trade Organization
Jun 08, 2021
The idea is backed by more than 60 countries, including the United States.
Cranberry supplements may aid memory in older adults
May 24, 2022
Improvement in neural functioning also was seen during a 12-week intervention.
FDA to prioritize full approval for Pfizer COVID-19 vaccine
Jul 16, 2021
Full approval could help boost vaccination efforts in the United States.
Skyrizi approved for psoriatic arthritis
Jan 26, 2022
The approval was based on two Phase 3 trials showing that more than 50% of patients receiving Skyrizi achieved an ACR20 response at 24 weeks.
Road traffic, railway noise linked to increased dementia risk
Sep 10, 2021
The general pattern showed higher hazard ratios with higher noise exposure, with levelling off or a decline at higher noise levels.
European Union passes U.S. in COVID-19 vaccination rates
Aug 09, 2021
Rates of people in the 27-member EU with at least one dose have climbed from less than 4% in mid-February to 60%, whereas rates in the United States rose from nearly 12% to less than 58%.
No fewer deaths seen with restricted IV fluid for septic shock
Jun 17, 2022
The rates of death at 90 days, serious adverse events, did not differ for patients with septic shock receiving restricted versus standard IV fluid therapy in the ICU.